Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 12972 | 805 | 36.5 | 51% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2144 | 4561 | MODY//MATURITY ONSET DIABETES OF THE YOUNG//NEONATAL DIABETES |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ALPHA FETOPROTEIN | Author keyword | 18 | 10% | 21% | 167 |
| 2 | ALPHA FETOPROTEIN RECEPTOR | Author keyword | 6 | 80% | 0% | 4 |
| 3 | RECAF | Author keyword | 4 | 75% | 0% | 3 |
| 4 | AFP RECEPTOR | Author keyword | 3 | 100% | 0% | 3 |
| 5 | COUNTERFLOW ISOTACHOPHORESIS | Author keyword | 3 | 100% | 0% | 3 |
| 6 | GROWTH INHIBITORY PEPTIDE | Author keyword | 3 | 100% | 0% | 3 |
| 7 | IMMUNOAFFINITY ELECTROCHROMATOGRAPHY | Author keyword | 3 | 100% | 0% | 3 |
| 8 | MONOCLONAL ANTIBODY 80G | Author keyword | 3 | 100% | 0% | 3 |
| 9 | MED SURG IMMUNOL | Address | 3 | 60% | 0% | 3 |
| 10 | JOINT FINNISH RUSSIAN BIOTECHNOL | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ALPHA FETOPROTEIN | 18 | 10% | 21% | 167 | Search ALPHA+FETOPROTEIN | Search ALPHA+FETOPROTEIN |
| 2 | ALPHA FETOPROTEIN RECEPTOR | 6 | 80% | 0% | 4 | Search ALPHA+FETOPROTEIN+RECEPTOR | Search ALPHA+FETOPROTEIN+RECEPTOR |
| 3 | RECAF | 4 | 75% | 0% | 3 | Search RECAF | Search RECAF |
| 4 | AFP RECEPTOR | 3 | 100% | 0% | 3 | Search AFP+RECEPTOR | Search AFP+RECEPTOR |
| 5 | COUNTERFLOW ISOTACHOPHORESIS | 3 | 100% | 0% | 3 | Search COUNTERFLOW+ISOTACHOPHORESIS | Search COUNTERFLOW+ISOTACHOPHORESIS |
| 6 | GROWTH INHIBITORY PEPTIDE | 3 | 100% | 0% | 3 | Search GROWTH+INHIBITORY+PEPTIDE | Search GROWTH+INHIBITORY+PEPTIDE |
| 7 | IMMUNOAFFINITY ELECTROCHROMATOGRAPHY | 3 | 100% | 0% | 3 | Search IMMUNOAFFINITY+ELECTROCHROMATOGRAPHY | Search IMMUNOAFFINITY+ELECTROCHROMATOGRAPHY |
| 8 | MONOCLONAL ANTIBODY 80G | 3 | 100% | 0% | 3 | Search MONOCLONAL+ANTIBODY+80G | Search MONOCLONAL+ANTIBODY+80G |
| 9 | HUMAN ALPHA FETOPROTEIN | 2 | 43% | 0% | 3 | Search HUMAN+ALPHA+FETOPROTEIN | Search HUMAN+ALPHA+FETOPROTEIN |
| 10 | AFP RECEPTORS | 1 | 100% | 0% | 2 | Search AFP+RECEPTORS | Search AFP+RECEPTORS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GROWTH INHIBITORY PEPTIDES | 11 | 100% | 1% | 6 |
| 2 | ALPHA FETOPROTEIN RECEPTORS | 9 | 83% | 1% | 5 |
| 3 | HUMAN ALPHA FETOPROTEIN | 9 | 32% | 3% | 23 |
| 4 | STIMULATED ESTRADIOL PRODUCTION | 8 | 100% | 1% | 5 |
| 5 | MULTISTEP IMMUNOCHEMICAL REACTIONS | 6 | 80% | 0% | 4 |
| 6 | RAT RHABDOMYOSARCOMA | 6 | 38% | 1% | 12 |
| 7 | ALPHA FETOPROTEIN RECEPTOR | 3 | 100% | 0% | 3 |
| 8 | ESTROGEN BINDING PROPERTIES | 3 | 100% | 0% | 3 |
| 9 | GROWTH INHIBITORY PEPTIDE | 3 | 100% | 0% | 3 |
| 10 | HUMAN CORD SERUM | 3 | 100% | 0% | 3 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TUMOUR BIOLOGY | 1 | 10% | 1% | 9 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Alpha-fetoprotein: a renaissance | 2013 | 16 | 123 | 77% |
| Alpha Fetoprotein is More than a Hepatocellular Cancer Biomarker: From Spontaneous Immune Response in Cancer Patients to the Development of an AFP-Based Cancer Vaccine | 2011 | 14 | 118 | 76% |
| alpha-fetoprotein growth inhibitory peptides: Potential leads for cancer therapeutics | 2003 | 25 | 35 | 91% |
| CHEMISTRY AND BIOLOGY OF ALPHA-FETOPROTEIN | 1991 | 168 | 244 | 41% |
| BIOLOGICAL ROLE OF ALPHA-FETOPROTEIN IN THE ENDOCRINOLOGIC FIELD - DATA AND HYPOTHESES | 1994 | 29 | 28 | 82% |
| Structural and functional mapping of alpha-fetoprotein | 2006 | 24 | 83 | 80% |
| Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family | 2011 | 13 | 100 | 47% |
| Alpha-fetoprotein structure and function: Relevance to isoforms, epitopes, and conformational variants | 2001 | 105 | 234 | 32% |
| Biological roles of alpha-fetoprotein during pregnancy and perinatal development | 2004 | 51 | 134 | 62% |
| Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study | 2010 | 3 | 43 | 84% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED SURG IMMUNOL | 3 | 60% | 0.4% | 3 |
| 2 | JOINT FINNISH RUSSIAN BIOTECHNOL | 2 | 67% | 0.2% | 2 |
| 3 | CYTOL EMBRYOL MOLEC | 1 | 100% | 0.2% | 2 |
| 4 | FETOPROT | 1 | 100% | 0.2% | 2 |
| 5 | UNIDAD VIROL BIOL DESARROLLO | 1 | 100% | 0.2% | 2 |
| 6 | AGNES GINGES HUMAN NEUROGENET NEUROIMMUNO | 1 | 50% | 0.1% | 1 |
| 7 | BP 8 | 1 | 50% | 0.1% | 1 |
| 8 | CIENCIAS BIOQUIM BIOL MOLEC CELULAR | 1 | 50% | 0.1% | 1 |
| 9 | CLIN MED CANC | 1 | 50% | 0.1% | 1 |
| 10 | IMMUNOL BOX 60400 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000223841 | BIOL MOLEC RUE CHEVAUX 67//HEPATOCYTE NUCLEAR FACTOR I//HEREDITARY PERSISTENCE OF ALPHA FETOPROTEIN |
| 2 | 0.0000176831 | DES GAMMA CARBOXY PROTHROMBIN//GOLGI PROTEIN 73//GP73 |
| 3 | 0.0000107666 | MATERNAL SERUM ALPHA FETOPROTEIN//MATERNAL SERUM ALPHA FETOPROTEIN MSAFP//MATERNAL SERUM HUMAN CHORIONIC GONADOTROPIN |
| 4 | 0.0000104410 | POLLEN PEPTIDE//L 4 OXALYSINE//ALPHA ANORDRIN |
| 5 | 0.0000065994 | ILAT STEROID RIA//UMASS CANC//INTRAUTERINE EXPOSURES |
| 6 | 0.0000065149 | ASPARTYL BETA HYDROXYLASE//HUMBUG//ASPARTYL ASPARAGINYL BETA HYDROXYLASE |
| 7 | 0.0000054167 | HEPATOID ADENOCARCINOMA//HEPATOID CARCINOMA//HEPATOID |
| 8 | 0.0000052499 | O AMINOAZOTOLUENE//GLUCOCORTICOID INDUCTION//ORTHO AMINOAZOTOLUENE |
| 9 | 0.0000052250 | CHOROID PLEXUS//EMBRYONIC CEREBROSPINAL FLUID//DESARROLLO TERATOL SISTEMA NERVIOSO |
| 10 | 0.0000044381 | GLYPICAN 3//GPC3//SIMPSON GOLABI BEHMEL SYNDROME |